Four things to know:
1. The Scripps Consortium for HIV/AIDS Vaccine Development received the seven-year grant from the National Institutes of Health.
2. The consortium’s 26 researchers will use the funding to advance HIV vaccine candidates to early stage clinical trials.
3. The research will occur at 14 affiliated institutions, including Scripps Research.
4. The experimental vaccines, designed to be administered in several stages, have demonstrated long-lasting protection against several HIV strains in animal studies.
More articles on clinical leadership and infection control:
Viewpoint: Antibiotic resistance should not make us feel helpless
Trends in nurse leaders’ salary and compensation: 5 report findings
Florida practice contacts police after mom films daughter licking medical supplies
